Appropriateness of omeprazole prescribing in Quebec's senior population

Canadian Journal of Gastroenterology

Volumn 14, Issue 8, 2000, Pages 676-680

  Gregoire, J P ^a   Moisan, J ^a   Chabot, I ^a   Gaudet, M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Administrative database; Appropriateness of prescribing; Drug use review; Elderly patients; Omeprazole

Indexed keywords

AMOXICILLIN; CIMETIDINE; CISAPRIDE; CLARITHROMYCIN; DOMPERIDONE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; METRONIDAZOLE; NIZATIDINE; OMEPRAZOLE; PROKINETIC AGENT; RANITIDINE; TETRACYCLINE;

AGING; ANTIMICROBIAL THERAPY; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0033786139     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/702980     Document Type: Article

References (45)

1. Omeprazole: A novel antisecretory agent for the treatment of acid-peptic disorders
2. Omeprazole
3. Omeprazole: A comprehensive review
4. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders
5. Omeprazole in the treatment of Zollinger-Ellison syndrome: A 4-year international study
6. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study
7. Medical treatment of peptic ulcer disease
8. Use of omeprazole in patients with Zollinger-Ellison syndrome
9. Management of gastro-oesophageal reflux disease. Are there alternatives to omeprazole?
10. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study
11. Omeprazole in the short-term treatment of reflux oesophagitis
12. Omeprazole in the treatment of gastroesophageal reflux disease
13. Comparison of omeprazole and cimetidine in reflux oesophagitis: Symptomatic, endoscopic, and histological evaluations
14. Reflux esophagitis
15. The medical management of reflux esophagitis. Role of antacids and acid inhibition
16. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine
17. 2-receptor antagonists in treating patients with peptic stricture and esophagitis
18. Le reflux gastro-oesophagien: Pour une approche diagnostique et therapeutique pragmatique
19. Current diagnosis and treatment of gastroesophageal reflux disease
20. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers
21. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori
22. Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen
23. Helicobacter pylori: The missing link in perspective
24. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on helicobacter pylori in peptic ulcer disease
25. Omeprazole versus ranitidine in the treatment of resistant duodenal ulcer
26. Omeprazole in the management of refractory duodenal ulcer
27. 2 receptor antagonists: A controlled clinical trial
28. Medical therapy of peptic ulcer disease
29. Refractory peptic lesions. Therapeutic strategies for ulcers and reflux esophagitis that resist standard regimens
30. Omeprazole. For resistant peptic ulcers and severe oesophageal reflux disease
31. Gastroesophageal reflux disease: An update on management
32. Acid-reflux disorders
33. Extent and variation of omeprazole prescribing in an elderly population of Ontario
34. A comparison of retrospective and concurrent drug utilization review of omeprazole
35. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the general practice research database
36. Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland
37. Determinants of initiation and suboptimal use of anti-ulcer medication: A study of the Quebec older population
38. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec
39. Use of explicit criteria and implicit judgements in a drug-use review program
40. Consensus conference participants. Canadian helicobacter pylori consensus conference
41. Alberta society of gastroenterology consensus statement: Helicobacter pylori in peptic ulcer disease